Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Joo Kim

Showing results (41-50 of 213) with videos related to

Pageof 22
Sort By:
Nuclear Medicine Communications|October 19, 2012
Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomographyKyoungjune Pak, Seong-Jang Kim, In Joo Kim, et al.
Annals of Nuclear Medicine|January 29, 2011
Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodulesSeong-Jang Kim, Bo Hyun Kim, Yun Kyung Jeon, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer ScreeningKyoungjune Pak, Seong-Jang Kim, In Joo Kim, et al.
Psychiatry and Clinical Neurosciences|October 28, 2008
Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary studySang Heon Song, In Joo Kim, Seong-Jang Kim, et al.
Scientific Reports|January 30, 2020
Cerebral glucose metabolism and Cerebral blood flow in thyroid dysfunction: An Activation Likelihood Estimation Meta-analysisKyoungjune Pak, Mijin Kim, Keunyoung Kim, et al.
Synapse (New York, N.Y.)|February 1, 2022
Limited power of dopamine transporter mRNA mapping for predicting dopamine transporter availabilityKyoungjune Pak, Seongho Seo, Myung Jun Lee, et al.
Nuklearmedizin. Nuclear Medicine|July 13, 2021
No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjectsHyun-Yeol Nam, Seongho Seo, Myung Jun Lee, et al.
Nuclear Medicine Communications|October 6, 2011
Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitisKeunyoung Kim, Seong-Jang Kim, In Joo Kim, et al.
Neural Regeneration Research|January 6, 2015
Quantification of Tc-99m-ethyl cysteinate dimer brain single photon emission computed tomography images using statistical probabilistic brain atlas in depressive end-stage renal disease patients: Correlation with disease severity and symptom factorsHeeyoung Kim, In Joo Kim, Seong-Jang Kim, et al.
Scientific Reports|March 21, 2020
Author Correction: Cerebral glucose metabolism and Cerebral blood flow in thyroid dysfunction: An Activation Likelihood Estimation Meta-analysisKyoungjune Pak, Mijin Kim, Keunyoung Kim, et al.
Pageof 22

Showing results (41-50 of 213) with videos related to

Sort By:
Pageof 22
Nuclear Medicine Communications|October 19, 2012
Impact of cytokines on diffuse splenic 18F-fluorodeoxyglucose uptake during positron emission tomography/computed tomographyKyoungjune Pak, Seong-Jang Kim, In Joo Kim, et al.
Annals of Nuclear Medicine|January 29, 2011
Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodulesSeong-Jang Kim, Bo Hyun Kim, Yun Kyung Jeon, et al.
Nuclear Medicine and Molecular Imaging|June 6, 2014
Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer ScreeningKyoungjune Pak, Seong-Jang Kim, In Joo Kim, et al.
Psychiatry and Clinical Neurosciences|October 28, 2008
Cerebral glucose metabolism abnormalities in patients with major depressive symptoms in pre-dialytic chronic kidney disease: statistical parametric mapping analysis of F-18-FDG PET, a preliminary studySang Heon Song, In Joo Kim, Seong-Jang Kim, et al.
Scientific Reports|January 30, 2020
Cerebral glucose metabolism and Cerebral blood flow in thyroid dysfunction: An Activation Likelihood Estimation Meta-analysisKyoungjune Pak, Mijin Kim, Keunyoung Kim, et al.
Synapse (New York, N.Y.)|February 1, 2022
Limited power of dopamine transporter mRNA mapping for predicting dopamine transporter availabilityKyoungjune Pak, Seongho Seo, Myung Jun Lee, et al.
Nuklearmedizin. Nuclear Medicine|July 13, 2021
No association of Brain-derived neurotrophic factor with striatal dopamine transporter availability in healthy subjectsHyun-Yeol Nam, Seongho Seo, Myung Jun Lee, et al.
Nuclear Medicine Communications|October 6, 2011
Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitisKeunyoung Kim, Seong-Jang Kim, In Joo Kim, et al.
Neural Regeneration Research|January 6, 2015
Quantification of Tc-99m-ethyl cysteinate dimer brain single photon emission computed tomography images using statistical probabilistic brain atlas in depressive end-stage renal disease patients: Correlation with disease severity and symptom factorsHeeyoung Kim, In Joo Kim, Seong-Jang Kim, et al.
Scientific Reports|March 21, 2020
Author Correction: Cerebral glucose metabolism and Cerebral blood flow in thyroid dysfunction: An Activation Likelihood Estimation Meta-analysisKyoungjune Pak, Mijin Kim, Keunyoung Kim, et al.
Pageof 22